Prague, Czech Republic

Clintrial s.r.o.

Atopic Dermatitis

Eczema

Dermatitis

Parkinson Disease

Methotrexate

Tavapadon

Cerevel Therapeutics

Medac

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

Atopic dermatitis is an ongoing condition that causes skin irritation, redness, and itchiness. Treatments are usually topical - applied to the skin (e.g., moisturisers or medicated creams) - but a wider variety of systemic treatments (that target the whole body) are needed for those whose condition does not improve with topical treatments. Methotrexate, a drug approved for similar conditions such as arthritis and psoriasis, has been shown to improve atopic dermatitis. This randomised, controlled clinical trial will investigate how effective.

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

The purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Parkinson's Disease.

Open-label Trial in Parkinson's Disease (PD)

Clintrial s.r.o. | Prague, Czech Republic

Site insights

Work at this site?

Active trials

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Open-label Trial in Parkinson's Disease (PD) (TEMPO-4)

Trial sponsors